Biotech · Private company
VectivBio AG
Track this companyFree. Adds VectivBio AG to your Dealase workspace and tells you when its record changes.
Clinical trials52 recruiting or active
Pipeline programs4From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline4
- ApraglutidePhase 3 · Short Bowel SyndromeClinicalTrials.gov · fetched Nov 12, 2026
- ApraglutidePhase 3 · Short Bowel Syndrome (SBS)ClinicalTrials.gov · fetched Nov 12, 2026
- ApraglutidePhase 2 · GVHDClinicalTrials.gov · fetched Nov 12, 2026
- ApraglutidePhase 1 · Chronic Kidney DiseaseClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials5
- A Study to Investigate the Efficacy and Safety of Apraglutide Compared With Placebo in Adult Participants With Short Bowel Syndrome Associated With Intestinal Failure (SBS-IF)PHASE3 · RECRUITING · started Aug 1, 2026ClinicalTrials.gov NCT07742735 · fetched Nov 12, 2026
- Proof-of-concept Trial of Apraglutide in Acute Graft Versus Host Disease (aGVHD)PHASE2 · TERMINATED · started May 25, 2022ClinicalTrials.gov NCT05415410 · fetched Nov 12, 2026
- Open-label Extension Trial to Evaluate the Long-term Safety of Apraglutide in Short Bowel Syndrome.PHASE3 · ACTIVE_NOT_RECRUITING · started Jul 13, 2021ClinicalTrials.gov NCT05018286 · fetched Nov 12, 2026
- Trial to Evaluate Efficacy and Safety of Apraglutide in SBS-IFPHASE3 · COMPLETED · started Jan 26, 2021ClinicalTrials.gov NCT04627025 · fetched Nov 12, 2026
- Study of Pharmacokinetics and Safety of Apraglutide in Participants With Normal and Impaired Kidney Function.PHASE1 · COMPLETED · started Dec 8, 2020ClinicalTrials.gov NCT04699032 · fetched Nov 12, 2026